Commentary: Animal models of neuroAIDS

Journal of Neuroimmune Pharmacology

Volumn 7, Issue 2, 2012, Pages 301-305

  Fox, Howard S ^a   Gendelman, Howard E ^a  

^a UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

Author keywords

Feline; Monkey; NeuroAIDS; Rodent

Indexed keywords

CENTRAL NERVOUS SYSTEM DISEASE; CENTRAL NERVOUS SYSTEM HIV INFECTION; FELINE IMMUNODEFICIENCY VIRUS; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MEDICAL RESEARCH; METABOLOMICS; NEUROPATHOLOGY; NONHUMAN; NOTE; PRIORITY JOURNAL; PROTEOMICS; RISK ASSESSMENT; SIMIAN IMMUNODEFICIENCY VIRUS; TRANSCRIPTOMICS; ANIMAL; DISEASE MODEL; EDITORIAL; HIV ASSOCIATED DEMENTIA; ORGANIZATION;

AIDS DEMENTIA COMPLEX; ANIMALS; CONGRESSES AS TOPIC; DISEASE MODELS, ANIMAL;

EID: 84866487916     PISSN: 15571890     EISSN: 15571904     Source Type: Journal    
DOI: 10.1007/s11481-012-9368-x     Document Type: Note

References (40)

1. Acharjee S, Noorbakhsh F, Stemkowski PL, Olechowski C, Cohen EA, Ballanyi K, Kerr B, Pardo C, Smith PA, Power C (2010) HIV-1 viral protein R causes peripheral nervous system injury associated with in vivo neuropathic pain. FASEB J: Official publication of the Federation of American Societies for Experimental Biology 24:4343-4353
2. Altice FL, Kamarulzaman A, Soriano VV, Schechter M, Friedland GH (2010) Treatment of medical, psychiatric, and substance-use comorbidities in people infected with HIV who use drugs. Lancet 376:367-387
3. Byrd DA, Fellows RP, Morgello S, Franklin D, Heaton RK, Deutsch R, Atkinson JH, Clifford DB, Collier AC, Marra CM, Gelman B, McCutchan JA, Duarte NA, Simpson DM, McArthur J, Grant I, Group C (2011) Neurocognitive impact of substance use in HIV infection. J Acquir Immune Defic Syndr 58:154-162
4. Chahroudi A, Bosinger SE, Vanderford TH, Paiardini M, Silvestri G (2012) Natural SIV hosts: showing AIDS the door. Science 335:1188-1193
5. Chang SL, Connaghan KP (2012) Behavioral and molecular evidence for a feedback interaction between morphine and HIV-1 viral proteins. J Neuroimmune Pharmacol (this issue)
6. Dash PK, Gorantla S, Gendelman HE, Knibbe J, Casale GP, Makarov E, Epstein AA, Gelbard HA, Boska MD, Poluektova LY (2011) Loss of neuronal integrity during progressive HIV-1 infection of humanized mice. J Neurosci 31:3148-3157
7. Deeks SG (2011) HIV infection, inflammation, immunosenescence, and aging. Annu Rev Med 62:141-155
8. Denton PW, Garcia JV (2011) Humanized mouse models of HIV infection. AIDS Rev 13:135-148
9. Dow SW, Poss ML, Hoover EA (1990) Feline immunodeficiency virus: a neurotropic lentivirus. J Acquir Immune Defic Syndr 3:658-668 (Pubitemid 20375237)
10. Eggert D, Dash PK, Gorantla S, Dou H, Schifitto G, Maggirwar SB, Dewhurst S, Poluektova L, Gelbard HA, Gendelman HE (2010) Neuroprotective activities of CEP-1347 in models of neuroAIDS. J Immunol 184:746-756
11. Elliott KJ, McArthur J, Simpson DM (2012) Peripheral neuropathy. In: Gendelman HE, Grant I, Everall IP, Fox HS, Gelbard HA, Lipton SA, Swindells S (eds) The neurology of AIDS, 3rd edn. Oxford University Press, New York, pp 536-546
12. Erichsen D, Lopez AL, Peng H, Niemann D, Williams C, Bauer M, Morgello S, Cotter RL, Ryan LA, Ghorpade A, Gendelman HE, Zheng J (2003) Neuronal injury regulates fractalkine: relevance for HIV-1 associated dementia. J Neuroimmunol 138:144-155 (Pubitemid 36566428)
13. Gersten M, Alirezaei M, Marcondes MC, Flynn C, Ravasi T, Ideker T, Fox HS (2009) An integrated systems analysis implicates EGR1 downregulation in simian immunodeficiency virus encephalitis-induced neural dysfunction. J Neurosci 29:12467-12476
14. Gong N, Liu J, Reynolds AD, Gorantla S, Mosley RL, Gendelman HE (2011) Brain ingress of regulatory T cells in a murine model of HIV-1 encephalitis. J Neuroimmunol 230:33-41
15. Gorantla S, Makarov E, Finke-Dwyer J, Castanedo A, Holguin A, Gebhart CL, Gendelman HE, Poluektova L (2010) Links between progressive HIV-1 infection of humanized mice and viral neuropathogenesis. Am J Pathol 177:2938-2949
16. Gorantla S, Poluektova L, Gendelman HE (2012a) Rodent models for HIV-associated neurocognitive disorders. Trends Neurosci 35:197-208
17. Gorantla S, Gendelman HE, Poluektova LY (2012b) Can humanized mice reflect the complex pathobiology of HIV-associated neurocognitive disorders? J Neuroimmune Pharmacol (this issue)
18. Hayman M, Arbuthnott G, Harkiss G, Brace H, Filippi P, Philippon V, Thomson D, Vigne R, Wright A (1993) Neurotoxicity of peptide analogues of the transactivating protein tat from Maedi-Visna virus and human immunodeficiency virus. Neuroscience 53:1-6 (Pubitemid 23083301)
19. Heaton RK et al (2011) HIV-associated neurocognitive disorders before and during the era of combination antiretroviral therapy: differences in rates, nature, and predictors. J Neurovirol 17:3-16
20. Jones GJ, Barsby NL, Cohen EA, Holden J, Harris K, Dickie P, Jhamandas J, Power C (2007) HIV-1 Vpr causes neuronal apoptosis and in vivo neurodegeneration. J Neurosci 27:3703-3711 (Pubitemid 46557688)
21. Kanmogne GD, Singh S, Roy U, Liu X, McMillan J, Gorantla S, Balkundi S, Smith N, Alnouti Y, Gautam N, Zhou Y, Poluektova L, Kabanov AV, Bronich T, Gendelman HE (2012) Mononuclear phagocyte intercellular crosstalk facilitates transmission of celltargeted nanoformulated antiretroviral drugs to human brain endothelial cells. International Journal of Nanomedicine In Press
22. Kaul M, Ma Q, Medders KE, Desai MK, Lipton SA (2007) HIV-1 coreceptors CCR5 and CXCR4 both mediate neuronal cell death but CCR5 paradoxically can also contribute to protection. Cell Death Differ 14:296-305 (Pubitemid 46092232)
23. Kelschenbach JL, Saini M, Hadas E, Gu CJ, Chao W, Bentsman G, Hong JP, Hanke T, Sharer LR, Potash MJ, Volsky DJ (2012) Mice chronically infected with Chimeric HIV resist peripheral and brain superinfection: a model of protective immunity to HIV. J Neuroimmune Pharmacol (this issue)
24. Kraft-Terry SD, Buch SJ, Fox HS, Gendelman HE (2009) A coat of many colors: neuroimmune crosstalk in human immunodeficiency virus infection. Neuron 64:133-145
25. Maung R, Medders KE, Sejbuk NE, Desai MK, Russo R, Kaul M (2012) Genetic knockouts suggest a critical role for HIV coreceptors in models of HIV gp120-induced brain injury. J Neuroimmune Pharmacol (this issue)
26. Meeker RB, Poulton W, Feng WH, Hudson L, Longo FM (2012) Suppression of immunodeficiency virus-associated neural damage by the p75 neurotrophin receptor ligand, LM11A-31, in an In Vitro Feline Model. J Neuroimmune Pharmacol (this issue)
27. Pendyala G, Trauger SA, Siuzdak G, Fox HS (2010) Quantitative plasma proteomic profiling identifies the vitamin E binding protein afamin as a potential pathogenic factor in SIV induced CNS disease. J Proteome Res 9:352-358
28. Potash MJ, Chao W, Bentsman G, Paris N, Saini M, Nitkiewicz J, Belem P, Sharer L, Brooks AI, Volsky DJ (2005) A mouse model for study of systemic HIV-1 infection, antiviral immune responses, and neuroinvasiveness. Proc Natl Acad Sci U S A 102:3760-3765 (Pubitemid 40354685)
29. Power C, Hui E, Vivithanaporn P, Acharjee S, Polyak M (2012) Delineating HIV-associated neurocognitive disorders using transgenic models: the neuropathogenic actions of Vpr. J Neuroimmune Pharmacol (this issue)
30. Reid Wet al (2001) An HIV-1 transgenic rat that develops HIV-related pathology and immunologic dysfunction. Proc Natl Acad Sci U S A 98:9271-9276 (Pubitemid 32743906)
31. Schmitz JE, Kuroda MJ, Santra S, Sasseville VG, Simon MA, Lifton MA, Racz P, Tenner-Racz K, Dalesandro M, Scallon BJ, Ghrayeb J, Forman MA, Montefiori DC, Rieber EP, Letvin NL, Reimann KA (1999) Control of viremia in simian immunodeficiency virus infection by CD8+ lymphocytes. Science 283:857-860
32. Toggas SM, Masliah E, Rockenstein EM, Rall GF, Abraham CR, Mucke L (1994) Central nervous system damage produced by expression of the HIV-1 coat protein gp120 in transgenic mice. Nature 367:188-193 (Pubitemid 24031702)
33. Weed M, Adams RJ, Hienz RD, Meulendyke KA, Linde ME, Clements JE, Mankowski JL, Zink MC (2012) SIV/macaque model of HIV infection in cocaine users: minimal effects of cocaine on behavior, virus replication, and CNS inflammation. J Neuroimmune Pharmacol (this issue)
34. Wiederin JL, Donahoe RM, Anderson JR, Yu F, Fox HS, Gendelman HE, Ciborowski PS (2010) Plasma proteomic analysis of simian immunodeficiency virus infection of rhesus macaques. J Proteome Res 9:4721-4731
35. Wikoff WR, Pendyala G, Siuzdak G, Fox HS (2008) Metabolomic analysis of the cerebrospinal fluid reveals changes in phospholipase expression in the CNS of SIV-infected macaques. J Clin Invest 118:2661-2669 (Pubitemid 351949793)
36. Williams K, Burdo TH (2012) Monocyte mobilization, activation markers, and unique macrophage populations in the brain: observations from SIV infected monkeys are informative with regard to pathogenic mechanisms of HIV infection in humans. J Neuroimmune Pharmacol (this issue)
37. Winkler JM, Chaudhuri AD, Fox HS (2012) Translating the brain transcriptome in NeuroAIDS: from non-human primates to humans. J Neuroimmune Pharmacol (this issue)
38. Yao H, Buch S (2012) Rodent model of HAND and drug abuse: exogenous administration of viral protein and cocaine. Journal of Neuroimmune Pharmacology 7 (this issue)
39. Yelamanchili SV, Chaudhuri AD, Chen LN, Xiong H, Fox HS (2010) MicroRNA-21 dysregulates the expression of MEF2C in neurons in monkey and human SIV/HIV neurological disease. Cell Death Dis 1:e77
40. Zhang K, McQuibban GA, Silva C, Butler GS, Johnston JB, Holden J, Clark-Lewis I, Overall CM, Power C (2003) HIV-induced metalloproteinase processing of the chemokine stromal cell derived factor-1 causes neurodegeneration. Nat Neurosci 6:1064-1071 (Pubitemid 37186198)